vTv Therapeutics, Inc. (VTVT)
34.09
+0.20
(+0.59%)
USD |
NASDAQ |
Aug 25, 13:16
vTv Therapeutics 1 Year Total Returns (Daily) : 111.8% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 111.8% |
| August 21, 2026 | 121.9% |
| August 20, 2026 | 120.5% |
| August 19, 2026 | 112.0% |
| August 18, 2026 | 102.8% |
| August 17, 2026 | 102.8% |
| August 14, 2026 | 96.86% |
| August 13, 2026 | 119.9% |
| August 12, 2026 | 119.3% |
| August 11, 2026 | 113.5% |
| August 10, 2026 | 144.9% |
| August 07, 2026 | 150.9% |
| August 06, 2026 | 136.8% |
| August 05, 2026 | 135.3% |
| August 04, 2026 | 121.5% |
| August 03, 2026 | 122.2% |
| July 31, 2026 | 116.4% |
| July 30, 2026 | 118.6% |
| July 29, 2026 | 108.7% |
| July 28, 2026 | 100.0% |
| July 27, 2026 | 99.61% |
| July 24, 2026 | 80.45% |
| July 23, 2026 | 85.91% |
| July 22, 2026 | 85.97% |
| July 21, 2026 | 96.24% |
| Date | Value |
|---|---|
| July 20, 2026 | 93.08% |
| July 17, 2026 | 103.5% |
| July 16, 2026 | 90.05% |
| July 15, 2026 | 93.66% |
| July 14, 2026 | 90.78% |
| July 13, 2026 | 85.66% |
| July 10, 2026 | 91.37% |
| July 09, 2026 | 103.2% |
| July 08, 2026 | 116.3% |
| July 07, 2026 | 129.0% |
| July 06, 2026 | 129.2% |
| July 02, 2026 | 135.1% |
| July 01, 2026 | 138.9% |
| June 30, 2026 | 151.0% |
| June 29, 2026 | 150.3% |
| June 26, 2026 | 125.6% |
| June 25, 2026 | 126.2% |
| June 24, 2026 | 126.2% |
| June 23, 2026 | 132.7% |
| June 22, 2026 | 118.2% |
| June 18, 2026 | 123.3% |
| June 17, 2026 | 115.7% |
| June 16, 2026 | 102.9% |
| June 15, 2026 | 118.5% |
| June 12, 2026 | 104.8% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Spyre Therapeutics, Inc. | 513.6% |
| ACADIA Pharmaceuticals, Inc. | 15.19% |
| Alnylam Pharmaceuticals, Inc. | -48.06% |
| Anika Therapeutics, Inc. | 121.1% |
| Savara, Inc. | 75.95% |